OSGEPL1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83348
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human OSGEPL1. Peptide sequence: IKPPLHHAKNCDFSFTGLQHVTDKIIMKKEKEEGIEKGQILSSAADIAAT The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for OSGEPL1 Antibody
![Western Blot: OSGEPL1 Antibody [NBP2-83348]](https://resources.bio-techne.com/images/products/OSGEPL1-Antibody-Western-Blot-NBP2-83348-img0001.jpg "Western Blot: OSGEPL1 Antibody [NBP2-83348]")
Western Blot: OSGEPL1 Antibody [NBP2-83348]
Western Blot: OSGEPL1 Antibody [NBP2-83348] - Host: Rabbit. Target Name: OSGEPL1. Sample Type: MCF7 Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for OSGEPL1 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: OSGEPL1
Alternate Names
EC 3.4.24.57, O-sialoglycoprotein endopeptidase like 1, O-sialoglycoprotein endopeptidase-like 1, O-sialoglycoprotein endopeptidase-like protein 1, probable O-sialoglycoprotein endopeptidase 2, putative sialoglycoprotease type 2, t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1
Gene Symbol
OSGEPL1
Additional OSGEPL1 Products
Product Specific Notices for OSGEPL1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...